Thrombotic thrombocytopenic purpura associated with everolimus use in a renal transplant patient

International Urology and Nephrology

Volumn 43, Issue 2, 2011, Pages 581-584

  Yılmaz, Vural Taner ^a   Koçak, Hüseyin ^a   Avcı, Ali B ^a   Salim, Ozan ^a   Ersoy, Fevzi F ^a   Süleymanlar, Gültekin ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Everolimus; Thrombotic microangiopathy

Indexed keywords

CREATININE; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANEMIA; ARTICLE; BLOOD SMEAR; BONE MARROW EXAMINATION; CASE REPORT; DRUG BLOOD LEVEL; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; FEMALE; FEVER; HEMODIALYSIS; HOSPITAL DISCHARGE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MEGAKARYOCYTE; MICROANGIOPATHY; MOTHER; PLASMAPHERESIS; POSTOPERATIVE PERIOD; STEROID THERAPY; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 79959740484     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-010-9755-2     Document Type: Article

References (15)

1. Manzoor K, Ahmed E, Akhtar F et al (2006) Cyclosporine withdrawal in post-renal transplant thrombotic microangiopathy. Clin Transpl 20:43-44
2. Ponticelli C, Banfi G (2006) Thrombotic microangiopathy after kidney transplantation. Transpl Int 19:789-792
3. Schwimmer J, Nadasdy TA, Spitalnik PF et al (2003) Denovo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidney Dis 41:471-473
4. Ardalan MR (2006) Review of thrombotic microangiopathy (TMA), post-renal transplant TMA. Saudi J Kidney Dis Transpl 17:235
5. Pelle G, Xu Y, Khoury N et al (2005) Thrombotic microangiopathy in marginal kidneys after sirolimus use. Am J Kidney Dis 46:1124
6. Couriel DR, Saliba R, Escalon MP et al (2005) Sirolimus in combination with tacrolimus, corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Hematol 130:409
7. Sartelet H, Toupance O, Lorenzato M et al (2005) Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys. Am J Transp 5:2441
8. Yango A, Morrissey P, Monaco A et al (2002) Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion, plasma Exchange. Clin Nephrol 58:77
9. Mohsin N, Nooyi C, Jha A, Budruddin M, Kamble P, Khalil M et al (2007) Retinal injury as an early manifestation of posttransplant thrombotic microangiopathy: recovery with plasma exchanges and conversion to sirolimus-case report and review of the literature. Transp Proc 39(4):1272-1275 (Pubitemid 46764912)
10. Copelovitch L, Kaplan BS (2008) The thrombotic microangiopathies. Pediatr Nephrol 23(10):1761-1767
11. Levandovsky M, Harvey D, Lara P, Wun T (2008) Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-Year clinical experience with 178 patients. J Hematol Oncol 1(1):23
12. Chiurchiu C, Ruggenenti P, Remuzzi G (2002) Thrombotic microangiopathy in renal transplantation. Ann Transp 7(1):28-33
13. Vogelbacher R, Wittmann S, Braun A, Daniel C, Hugo C (2007) The mTOR inhibitor everoimus induces proteinuria and renal deterioration in the remnant kidney model in the rat. Transplantation 84(11):1492-1499 (Pubitemid 350294725)
14. Alexandru S, Ortiz A, Baldovi S, Milicua JM, Ruiz-Escribano E, Eqido J et al (2008) Severe everolimus associated pneumonitis in a renal transplant recipient. Nephrol Dial Transp 23(10):3353-3355
15. Daniel C, Renders L, Aman K, Schulze-Lohoff E, Hauser IA, Hugo C (2005) Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat. Am J Transp 5(12):2849-2861 (Pubitemid 43923945)